24352-51-0

Basic information

• Product Name: 3,5-Cycloergosta-6,8(14),22-triene
• Synonyms: 3,5-Cycloergosta-6,8(14),22-triene
• CAS NO: 24352-51-0
• Molecular Formula: C₂₈H₄₂
• Molecular Weight: 378.63308
• Mol File: 24352-51-0.mol

Chemical Properties

• Boiling Point: 468.3°C at 760 mmHg
• Flash Point: 230.1°C
• Appearance: /
• Density: 1g/cm³
• Vapor Pressure: 1.71E-08mmHg at 25°C
• Refractive Index: 1.551
• CAS DataBase Reference: 3,5-Cycloergosta-6,8(14),22-triene(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-Cycloergosta-6,8(14),22-triene(24352-51-0)
• EPA Substance Registry System: 3,5-Cycloergosta-6,8(14),22-triene(24352-51-0)

Safety Data

• Hazardous Substances Data: 24352-51-0(Hazardous Substances Data)

Usage

Uses

Used in Healthcare Applications:
3,5-Cycloergosta-6,8(14),22-triene is used as a health supplement for its potential role in reducing inflammation and protecting against cardiovascular disease. Its anti-inflammatory properties and cardiovascular protective effects make it a promising candidate for the prevention and treatment of related health conditions.
Used in Pharmaceutical Production:
3,5-Cycloergosta-6,8(14),22-triene is used as a precursor in the synthesis of hormones and other pharmaceutical compounds. Its importance in hormone synthesis makes it a valuable component in the development of medications targeting hormonal imbalances and related health issues.
Used in Food Additive Industry:
3,5-Cycloergosta-6,8(14),22-triene is used as a food additive for its potential health benefits. Its presence in food products may contribute to the reduction of inflammation and cardiovascular protection, enhancing the nutritional value and health benefits of these products.
Used in Animal Feed Industry:
3,5-Cycloergosta-6,8(14),22-triene is used as an additive in animal feed for its potential health benefits and growth promotion in livestock. Its inclusion in animal feed may improve the overall health and productivity of animals, contributing to the quality and sustainability of the livestock industry.

InChI:InChI=1/C28H42/c1-18(2)19(3)7-8-20(4)23-9-10-24-22-12-16-28-17-21(28)11-15-27(28,6)25(22)13-14-26(23,24)5/h7-8,12,16,18-21,23,25H,9-11,13-15,17H2,1-6H3/b8-7-

Upstream product

• 57-87-4 Ergosterol 
• 108-24-7 acetic anhydride 
• 2774-59-6 3α,5α-cyclo-ergosta-7,22t-dien-6β-ol 
• 57760-53-9 (22E,24S)-24-methylcholesta-5,7,22-trien-3β-ol 
• 2774-59-6 (22E)-3α,5-cyclo-5α-ergosta-7,22-dien-6β-ol 
• 15072-98-7 methylsulfonylergosterol 
• 3037-46-5 (22E)-3α,5-cyclo-5α-ergosta-7,22-dien-6β-one 
• 24352-41-8 phosphorodichloridic acid ergosta-5,7,22t-trien-3β-yl ester 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 57-87-4 Ergosterol 

Relevant articles and documents

Biological Activity of Brassinosteroids – Direct Comparison of Known and New Analogs in planta

A systematic investigation of structural modifications of brassinosteroids is presented. We describe in detail their synthetic preparation, which includes significant improvements of previously reported protocols as well as access to new analogs with functional modifications of the steroid skeleton and of the C(17)-attached side chain. We report the biological potency of the prepared brassinosteroid analogs as plant hormones, which were carefully established in the French bean second internode elongation assay and discuss our observations in light of the recently reported structural data detailing the molecular interactions between brassinolide in the trimeric complex with the protein receptors kinases BRASSINOSTEROID INSENSITIVE 1 (BRI1) and SOMATIC EMBRYOGENESIS RECEPTOR KINASE 1 (SERK1). In a further part of this work we describe the preparation of H2O-soluble pro-forms of 24-epicastasterone and we discuss their physical properties, hydrolytic stabilities and biological activity.

The cathodic reduction of activated olefins. Experimental conditions allowing the specific hydrogenation of the enone derived from ergosterol

The reduction of the bulky enone 1 derived from ergosterol was performed in non-aqueous media without and with proton donor. A fairly stable anion radical was obtained and characterized. When 1 was reduced in the presence of an efficient proton donor (benzoic acid, trifluoroacetic acid) saturation of the double bond was achieved with reasonable yield. The overall process as a function of experimental conditions is discussed.

Approaches towards the synthesis of a sulfur analog of ergosterol peroxide

In an analogous fashion to the preparation of ergosterol peroxide from singlet oxygen, the preparation of its sulfur analog was attempted via the Diels-Alder addition of diatomic sulfur to ergosterol.Two of the recently reported methods for generating and

SYNTHESIS OF 3β-FLUORO DERIVATIVES OF 7-DEHYDROCHOLESTEROL AND OF ERGOSTEROL

It has been established that the fluorination of 3β-hydroxy-Δ5,7-steroids, unlike that of 3β-hydroxy-Δ5-steroids, does not lead to the formation of 3β-fluoro derivatives.The reaction products are 3α,5α-cyclo-Δ6,8(14) compo